Pathophysiology of SPINK Mutations in Pancreatic Development and Disease

Endocrinology and Metabolism Clinics of North America

Volumn 35, Issue 2, 2006, Pages 345-356

  Liddle, Rodger A ^a  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SERINE PROTEINASE INHIBITOR; TRANSMEMBRANE CONDUCTANCE REGULATOR; TRYPSIN; TRYPSIN INHIBITOR; TRYPSINOGEN;

ALCOHOLIC PANCREATITIS; CHRONIC PANCREATITIS; DEVELOPMENT; DIGESTION; DISEASE COURSE; DISEASE PREDISPOSITION; DISEASE SEVERITY; ENVIRONMENTAL FACTOR; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; FAMILIAL DISEASE; GENE FUNCTION; GENE IDENTIFICATION; GENE MUTATION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC DISORDER; GENETIC VARIABILITY; HEREDITY; HUMAN; NONHUMAN; ORGANOGENESIS; PANCREAS DISEASE; PANCREAS FUNCTION; PANCREATITIS; PATHOGENESIS; PATHOPHYSIOLOGY; PHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; RISK FACTOR;

ANIMALS; CARRIER PROTEINS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; ENZYME ACTIVATION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MICE; MICE, KNOCKOUT; PANCREATITIS; POINT MUTATION; TRYPSINOGEN;

EID: 33646040097     PISSN: 08898529     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ecl.2006.02.012     Document Type: Review

References (51)

1. Scheele G., Adler G., and Kern H. Exocytosis occurs at the lateral plasma membrane of the pancreatic acinar cell during supramaximal secretagogue stimulation. Gastroenterology 92 (1987) 345-353
2. Bialek R., Willemer S., Arnold R., et al. Evidence of intracellular activation of serine proteases in acute cerulein-induced pancreatitis in rats. Scand J Gastroenterol 26 (1991) 190-196
3. Hofbauer B., Saluja A.K., Lerch M.M., et al. Intra-acinar cell activation of trypsinogen during caerulein-induced pancreatitis in rats. Am J Physiol 275 (1998) G352-G362
4. Steer M.L. Frank Brooks memorial Lecture: the early intraacinar cell events which occur during acute pancreatitis. Pancreas 17 (1998) 31-37
5. Saluja A., Saluja M., Villa A., et al. Pancreatic duct obstruction in rabbits causes digestive zymogen and lysosomal enzyme colocalization. J Clin Invest 84 (1989) 1260-1266
6. Luthen R., Niederau C., Niederau M., et al. Influence of ductal pressure and infusates on activity and subcellular distribution of lysosomal enzymes in the rat pancreas. Gastroenterology 109 (1995) 573-581
7. Kazal L.A., Spicer D.S., and Brahinsky R.A. Isolation of crystalline trypsin inhibitor-anticoagulant protein from the pancreas. J Am Chem Soc 70 (1948) 304-340
8. Horii A., Kobayashi T., Tomita N., et al. Primary structure of human pancreatic secretory trypsin inhibitor (PSTI) gene. Biochem Biophys Res Commun 149 (1987) 635-641
9. Bartelt D.C., Shapanka R., and Greene L.J. The primary structure of the human pancreatic secretory trypsin inhibitor: amino acid sequence of the reduced S-aminoethylated protein. Arch Biochem Biophys 179 (1977) 189-199
10. Laskowski M., and Wu F.C. Temporary inhibition of trypsin. J Biol Chem 204 (1953) 797-805
11. Comfort M.W., and Steinberg A.G. Pedigree of a family with hereditary chronic relapsing pancreatitis. Gastroenterology 21 (1952) 54-63
12. McElroy R., and Christiansen P.A. Hereditary pancreatitis in a kinship associated with portal vein thrombosis. Am J Med 52 (1972) 228-241
13. Whitcomb D.C., Gorry M.C., Preston R.A., et al. Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene. Nat Genet 14 (1996) 141-145
14. Ferec C., Raguenes O., Salomon R., et al. Mutations in the cationic trypsinogen gene and evidence for genetic heterogeneity in hereditary pancreatitis. J Med Genet 36 (1999) 228-232
15. Teich N., Ockenga J., Hoffmeister A., et al. Chronic pancreatitis associated with an activation peptide mutation that facilitates trypsin activation. Gastroenterology 119 (2000) 461-465
16. Pfutzer R., Myers E., Applebaum-Shapiro S., et al. Novel cationic trypsinogen (PRSS1) N29T and R122C mutations cause autosomal dominant hereditary pancreatitis. Gut 50 (2002) 271-272
17. Chen J.M., Mercier B., Audrezet M.P., et al. Mutational analysis of the human pancreatic secretory trypsin inhibitor (PSTI) gene in hereditary and sporadic chronic pancreatitis. J Med Genet 37 (2000) 67-69
18. Witt H., Luck W., Hennies H.C., et al. Mutations in the gene encoding the serine protease inhibitor, Kazal type 1 are associated with chronic pancreatitis. Nat Genet 25 (2000) 213-216
19. Marchbank T., Freeman T.C., and Playford R.J. Human pancreatic secretory trypsin inhibitor: distribution, actions and possible role in mucosal integrity and repair. Digestion 59 (1998) 167-174
20. Pfutzer R.H., Barmada M.M., Brunskill A.P., et al. SPINK1/PSTI polymorphisms act as disease modifiers in familial and idiopathic chronic pancreatitis. Gastroenterology 119 (2000) 615-623
21. Witt H., Luck W., Becker M., et al. Mutation in the SPINK1 trypsin inhibitor gene, alcohol use, and chronic pancreatitis. JAMA 285 (2001) 2716-2717
22. Chen J.M., Mercier B., Audrezet M.P., et al. Mutations of the pancreatic secretory trypsin inhibitor (PSTI) gene in idiopathic chronic pancreatitis. Gastroenterology 120 (2001) 1061-1064
23. Ockenga J., Dork T., and Stuhrmann M. Low prevalence of SPINK1 gene mutations in adult patients with chronic idiopathic pancreatitis. J Med Genet 38 (2001) 243-244
24. Kaneko K., Nagasaki Y., Furukawa T., et al. Analysis of the human pancreatic secretory trypsin inhibitor (PSTI) gene mutations in Japanese patients with chronic pancreatitis. J Hum Genet 46 (2001) 293-297
25. Kuwata K., Hirota M., Sugita H., et al. Genetic mutations in exons 3 and 4 of the pancreatic secretory trypsin inhibitor in patients with pancreatitis. J Gastroenterol 36 (2001) 612-618
26. Plendl H., Siebert R., Steinemann D., et al. High frequency of the N34S mutation in the SPINK1 gene in chronic pancreatitis detected by a new PCR-RFLP assay. Am J Med Genet 100 (2001) 252-253
27. Noone P.G., Zhou Z., Silverman L.M., et al. Cystic fibrosis gene mutations and pancreatitis risk: relation to epithelial ion transport and trypsin inhibitor gene mutations. Gastroenterology 121 (2001) 1310-1319
28. Threadgold J., Greenhalf W., Ellis I., et al. The N34S mutation of SPINK1 (PSTI) is associated with a familial pattern of idiopathic chronic pancreatitis but does not cause the disease. Gut 50 (2002) 675-681
29. Truninger K., Witt H., Kock J., et al. Mutations of the serine protease inhibitor, Kazal type 1 gene, in patients with idiopathic chronic pancreatitis. Am J Gastroenterol 97 (2002) 1133-1137
30. Audrezet M.P., Chen J.M., Le Marechal C., et al. Determination of the relative contribution of three genes-the cystic fibrosis transmembrane conductance regulator gene, the cationic trypsinogen gene, and the pancreatic secretory trypsin inhibitor gene-to the etiology of idiopathic chronic pancreatitis. Eur J Hum Genet 10 (2002) 100-106
31. Drenth J.P., te Morsche R., and Jansen J.B. Mutations in serine protease inhibitor Kazal type 1 are strongly associated with chronic pancreatitis. Gut 50 (2002) 687-692
32. Gomez-Lira M., Bonamini D., Castellani C., et al. Mutations in the SPINK1 gene in idiopathic pancreatitis Italian patients. Eur J Hum Genet 11 (2003) 543-546
33. Schneider A., Barmada M.M., Slivka A., et al. Clinical characterization of patients with idiopathic chronic pancreatitis and SPINK1 Mutations. Scand J Gastroenterol 39 (2004) 903-904
34. Le Marechal C., Chen J.M., Le Gall C., et al. Two novel severe mutations in the pancreatic secretory trypsin inhibitor gene (SPINK1) cause familial and/or hereditary pancreatitis. Hum Mutat 23 (2004) 205
35. Schneider A., Suman A., Rossi L., et al. SPINK1/PSTI mutations are associated with tropical pancreatitis and type II diabetes mellitus in Bangladesh. Gastroenterology 123 (2002) 1026-1030
36. Bhatia E., Choudhuri G., Sikora S.S., et al. Tropical calcific pancreatitis: strong association with SPINK1 trypsin inhibitor mutations. Gastroenterology 123 (2002) 1020-1025
37. Hassan Z., Mohan V., Ali L., et al. SPINK1 is a susceptibility gene for fibrocalculous pancreatic diabetes in subjects from the Indian subcontinent. Am J Hum Genet 71 (2002) 964-968
38. Chandak G.R., Idris M.M., Reddy D.N., et al. Mutations in the pancreatic secretory trypsin inhibitor gene (PSTI/SPINK1) rather than the cationic trypsinogen gene (PRSS1) are significantly associated with tropical calcific pancreatitis. J Med Genet 39 (2002) 347-351
39. Schneider A., Pfutzer R.H., Barmada M.M., et al. Limited contribution of the SPINK1 N34S mutation to the risk and severity of alcoholic chronic pancreatitis: a report from the United States. Dig Dis Sci 48 (2003) 1110-1115
40. Perri F., Piepoli A., Stanziale P., et al. Mutation analysis of the cystic fibrosis transmembrane conductance regulator (CFTR) gene, the cationic trypsinogen (PRSS1) gene, and the serine protease inhibitor, Kazal type 1 (SPINK1) gene in patients with alcoholic chronic pancreatitis. Eur J Hum Genet 11 (2003) 687-692
41. Cohn J.A., Friedman K.J., Noone P.G., et al. Relation between mutations of the cystic fibrosis gene and idiopathic pancreatitis. N Engl J Med 339 (1998) 653-658
42. Sharer N., Schwarz M., Malone G., et al. Mutations of the cystic fibrosis gene in patients with chronic pancreatitis. N Engl J Med 339 (1998) 645-652
43. Cohn J.A., Mitchell R.M., and Jowell P.S. The impact of cystic fibrosis and PSTI/SPINK1 gene mutations on susceptibility to chronic pancreatitis. Clin Lab Med 25 (2005) 79-100
44. Felley C., Morris M.A., Wonkam A., et al. The role of CFTR and SPINK-1 mutations in pancreatic disorders in HIV-positive patients: a case-control study. AIDS 18 (2004) 1521-1527
45. Felderbauer P., Hoffmann P., Einwachter H., et al. A novel mutation of the calcium sensing receptor gene is associated with chronic pancreatitis in a family with heterozygous SPINK1 mutations. BMC Gastroenterol 3 (2003) 34
46. Rinderknecht H. Pancreatic secretory enzymes. In: Go V.L.W., DiMagno J.D., Gardner J.D., et al. (Eds). The pancreas: biology, pathophysiology, and disease (1993), Raven Press, New York 219-251
47. Figarella C., Negri G.A., and Guy O. The two human trypsinogens. Inhibition spectra of the two human trypsins derived from their purified zymogens. Eur J Biochem 53 (1975) 457-463
48. Hirota M., Kuwata K., Ohmuraya M., et al. From acute to chronic pancreatitis: the role of mutations in the pancreatic secretory trypsin inhibitor gene. JOP 4 (2003) 83-88
49. Szmola R., Kukor Z., and Sahin-Toth M. Human mesotrypsin is a unique digestive protease specialized for the degradation of trypsin inhibitors. J Biol Chem 278 (2003) 48580-48589
50. Ohmuraya M., Hirota M., Araki M., et al. Autophagic cell death of pancreatic acinar cells in serine protease inhibitor Kazal type 3-deficient mice. Gastroenterology 129 (2005) 696-705
51. Nathan J.D., Romac J., Peng R.Y., et al. Transgenic expression of pancreatic secretory trypsin inhibitor-I ameliorates secretagogue-induced pancreatitis in mice. Gastroenterology 128 (2005) 717-727